Buy or sell Front Range Biosciences stock pre IPO via an EquityZen fund
Front Range Biosciences Stock
Agricultural science for cannabis and hemp
About Front Range Biosciences Stock
CEO: Jon Vaught, PhD, Organic Chemistry, CU Boulder, 10 years biotech startup experience with 4 companies CSO: Chris Zalewski, PhD, Plant Biology, UC Davis, 20 years plant biotechnology experience COO: Nick Hofmeister, MBA, MIT, raised $250 million, co-founder 4 biotech companies Problem: Due to 60 years of prohibition, cannabis and hemp cultivators don’t have access to the bioscience tools that are used in modern agriculture. Cannabis and hemp growers are losing money due to disease, reduced yields, and un-differntiated product. Solution: Use known agricultural biotechnology (e.g., tissue culture, cryopreservation, analytical chemistry, genomics and marker assisted breeding) to improve yields, reduce disease, and create novel strains.